Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Ann Emerg Med. 2014 Mar 6;64(4):376–384. doi: 10.1016/j.annemergmed.2014.01.031

Table 3.

Testing in ACASI Participants

Recommendation Group* Total Received Testing (% Total) Gonorrhea Positive Chlamydia Positive
Female N=466 1 234 (50.2%) 131 (56.0%) 9 (6.9%) 25 (19.1%)
2 72 (15.4%) 20 (27.8%) 1 (5.0%) 4 (20.0%)
3 155 (33.2%) 14 (9.0%) 0 2 (14.3%)
4 5 (1.1%) 1 (20.0%) 0 0

Male N=334 1 185 (55.4%) 90 (48.6%) 3 (3.3%) 10 (11%)
2 16 (4.8%) 3 (18.8%) 0 0
3 124 (37.1%) 5 (4.0%) 0 0
4 9 (2.7%) 1 (11.1%) 0 0
*

1=Patients should be offered testing, based on CDC criteria or endorsed symptoms; 2= Patient does not need testing but sexual history indicated elevated infection risk; 3= Patient does not need testing or have elevated infection risk; 4= Patient left too many answers blank to provide a recommendation.

1 man and 6 women tested positive for both chlamydia and gonorrhea

ACASI – Audio-enhanced Computer-Assisted Self-Interview; CDC – Centers for Disease Control and Prevention